Key Performance
More- Earnings Score: 28
- Momentum Score: 49
- True Yield: N/A
- Financial Health Score: 10
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Why Neogen Stock Blasted More Than 31% Higher Today
Neogen stock surged over 31% after posting a beat-and-raise fiscal Q2 earnings report. Despite revenue declining nearly 3% year-over-year to $224.7 million and net income dropping slightly, the company crushed analyst expectations and raised full-year guidance. However, the analyst expresses caution about the stock's future, noting the revenue decline and suggesting investors may be overexcited about the results.
01/08/2026, 7:04 PM • The Motley Fool
Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education
Neogen Corporation has renewed its sponsorship with US Equestrian, focusing on educational materials about equine botulism prevention and treatment. The collaboration aims to raise awareness about the potentially deadly neurotoxin and promote horse health through scientific resources.
09/25/2025, 5:26 PM • Benzinga
A class action lawsuit has been filed against Neogen Corporation alleging false and misleading statements about company integration and financial performance during the period of January 5, 2023 to June 3, 2025.
09/16/2025, 4:00 PM • GlobeNewswire
Neogen Corporation faces a securities class action lawsuit alleging failure to disclose material information during January 5, 2023 to June 3, 2025, with stock price dropping significantly after revenue and earnings guidance announcements.
09/15/2025, 10:25 PM • GlobeNewswire
Rosen Law Firm alerts Neogen Corporation investors about a September 16, 2025 deadline for a securities class action lawsuit related to allegedly misleading statements about company integration and performance.
09/15/2025, 9:30 PM • GlobeNewswire
Kahn Swick & Foti, LLC alerts investors about a class action lawsuit against Neogen Corporation for allegedly failing to disclose material financial information between January 5, 2023 and June 3, 2025, resulting in significant stock price declines.
09/09/2025, 10:07 PM • GlobeNewswire
A class action lawsuit has been filed against Neogen Corporation alleging misrepresentation of 3M integration status and financial performance, with stock price declining significantly after revealing integration challenges and cutting financial guidance.
09/07/2025, 10:56 AM • GlobeNewswire
Neogen Corporation faces a class action lawsuit alleging false statements about the integration of a former 3M food safety business, with claims of misleading investors about integration progress and margin performance.
09/04/2025, 12:16 PM • Benzinga
Neogen Corporation faces a securities class action lawsuit alleging failure to disclose material information during January 2023 to June 2025, with stock price dropping significantly after revenue and EBITDA margin disclosures.
09/03/2025, 9:06 PM • GlobeNewswire
Law firm alerts investors about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations across different sectors.
09/03/2025, 12:00 PM • GlobeNewswire
Kahn Swick & Fosti, LLC alerts investors about a class action lawsuit against Neogen Corporation for allegedly failing to disclose material financial information between January 5, 2023 and June 3, 2025, resulting in significant stock price declines.
09/02/2025, 9:37 PM • GlobeNewswire
Rosen Law Firm alerts Neogen Corporation investors who purchased stock between January 5, 2023 and June 3, 2025 about a potential securities class action lawsuit regarding allegedly misleading statements about company integration.
09/01/2025, 6:45 AM • GlobeNewswire
NEOG 周一截止日期：獲評為頂尖、業界領先的律師事務所 ROSEN，呼籲損失超過 10 萬美元的 Neogen Corporation 投資人，在證券集體訴訟的重要截止日前尋求法律意見 – NEOG
Rosen Law Firm is notifying investors who purchased Neogen Corporation stock between January 5, 2023, and June 3, 2025, about a potential securities class action lawsuit alleging false and misleading statements regarding company integration progress.
09/01/2025, 6:45 AM • GlobeNewswire
Law firm Bragar Eagel & Squire alerts investors about class action lawsuits against Neogen, Alto Neuroscience, RxSight, and Replimune Group, citing potential securities violations and misleading statements.
08/30/2025, 8:20 AM • GlobeNewswire
Neogen Corporation faces a class action lawsuit alleging misleading statements about business performance, with stock price declining after disclosing financial challenges related to 3M acquisition integration and internal control weaknesses.
08/29/2025, 12:00 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.